XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Interim Condensed Consolidated Statements of (Loss) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues:    
Revenues $ 28,735 $ 34,391
Cost of revenues 5,315 6,404
Gross profit 23,420 27,987
Operating expenses:    
Research and development, net 20,791 20,210
Sales and marketing 3,045 2,923
General and administrative 4,048 3,636
Amortization of intangible assets 329 750
Total operating expenses 28,213 27,519
Operating income (loss) (4,793) 468
Financial income, net 1,455 282
Remeasurement of marketable equity securities (117) (1,131)
Loss before taxes on income (3,455) (381)
Income tax expense 1,417 1,315
Net loss $ (4,872) $ (1,696)
Basic net loss per share (in dollars per share) $ (0.21) $ (0.07)
Diluted net loss per share (in dollars per share) $ (0.21) $ (0.07)
Weighted-average shares used to compute net loss per share (in thousands):    
Basic (in shares) 23,334 23,103
Diluted (in shares) 23,334 23,103
License [Member]    
Revenues:    
Revenues $ 20,721 $ 22,393
Royalty [Member]    
Revenues:    
Revenues $ 8,014 $ 11,998